Catalyst Wire Dossier Catalyst Wire Dossier

Inaticabtagene Autoleucel

· Juventas Cell Therapy Ltd
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Inaticabtagene Autoleucel, covering 2024-09-19 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy [Phase 1]

See pricing